-
1
-
-
84856654320
-
Hereditary angio-oedema
-
Longhurst H, and Cicardi M. Hereditary angio-oedema. Lancet 379:474-481, 2012.
-
(2012)
Lancet
, vol.379
, pp. 474-481
-
-
Longhurst, H.1
Cicardi, M.2
-
2
-
-
84877113122
-
Hereditary angioedema: Epidemiology, management, and role of icatibant
-
Ghazi A, and Grant JA. Hereditary angioedema: epidemiology, management, and role of icatibant. Biologics 7:103-113, 2013.
-
(2013)
Biologics
, vol.7
, pp. 103-113
-
-
Ghazi, A.1
Grant, J.A.2
-
3
-
-
4444225379
-
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
-
Agostoni A, Aygoren-Pursun E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51-S131, 2004.
-
(2004)
J Allergy Clin Immunol
, vol.114
, pp. S51-S131
-
-
Agostoni, A.1
Aygoren-Pursun, E.2
Binkley, K.E.3
-
4
-
-
84858966009
-
Hereditary and acquired complement component 1 esterase inhibitor deficiency: A review for the hematologist
-
Cicardi M, and Johnston DT. Hereditary and acquired complement component 1 esterase inhibitor deficiency: A review for the hematologist. Acta Haematol 127:208-220, 2012.
-
(2012)
Acta Haematol
, vol.127
, pp. 208-220
-
-
Cicardi, M.1
Johnston, D.T.2
-
5
-
-
60949104520
-
C1-inhibitor deficiency and angioedema: Molecular mechanisms and clinical progress
-
Cugno M, Zanichelli A, Foieni F, et al. C1-inhibitor deficiency and angioedema: Molecular mechanisms and clinical progress. Trends Mol Med 15:69-78, 2009.
-
(2009)
Trends Mol Med
, vol.15
, pp. 69-78
-
-
Cugno, M.1
Zanichelli, A.2
Foieni, F.3
-
6
-
-
77954311687
-
The plasma bradykinin-forming pathways and its interrelationships with complement
-
Kaplan AP, and Ghebrehiwet B. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol 47:2161-2169, 2010.
-
(2010)
Mol Immunol
, vol.47
, pp. 2161-2169
-
-
Kaplan, A.P.1
Ghebrehiwet, B.2
-
7
-
-
84987657462
-
The humanistic burden of hereditary angioedema: Results from the Burden of Illness Study in Europe
-
Caballero T, Aygoren-Pursun E, Bygum A, et al. The humanistic burden of hereditary angioedema: Results from the Burden of Illness Study in Europe. Allergy Asthma Proc 35:47-53, 2014.
-
(2014)
Allergy Asthma Proc
, vol.35
, pp. 47-53
-
-
Caballero, T.1
Aygoren-Pursun, E.2
Bygum, A.3
-
8
-
-
79956316229
-
Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 2004-2007
-
Zilberberg MD, Nathanson BH, Jacobsen T, and Tillotson G. Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 2004-2007. Allergy Asthma Proc 32:248-254, 2011.
-
(2011)
Allergy Asthma Proc
, vol.32
, pp. 248-254
-
-
Zilberberg, M.D.1
Nathanson, B.H.2
Jacobsen, T.3
Tillotson, G.4
-
9
-
-
84865676871
-
Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency
-
Bork K, Hardt J, and Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 130:692-697, 2012.
-
(2012)
J Allergy Clin Immunol
, vol.130
, pp. 692-697
-
-
Bork, K.1
Hardt, J.2
Witzke, G.3
-
10
-
-
84873508381
-
Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment
-
Maurer M, Aberer W, Bouillet L, et al. Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS One 8:e53773, 2013.
-
(2013)
PLoS One
, vol.8
, pp. e53773
-
-
Maurer, M.1
Aberer, W.2
Bouillet, L.3
-
11
-
-
77955295556
-
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema
-
Cicardi M, Banerji A, Bracho F, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 363:532-541, 2010.
-
(2010)
N Engl J Med
, vol.363
, pp. 532-541
-
-
Cicardi, M.1
Banerji, A.2
Bracho, F.3
-
12
-
-
82955233701
-
Randomized placebo-controlled trial of the bradykinin B(2) receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: The FAST-3 trial
-
Lumry WR, Li HH, Levy RJ, et al. Randomized placebo-controlled trial of the bradykinin B(2) receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol 107:529-537, 2011.
-
(2011)
Ann Allergy Asthma Immunol
, vol.107
, pp. 529-537
-
-
Lumry, W.R.1
Li, H.H.2
Levy, R.J.3
-
13
-
-
84907044494
-
Treatment of hereditary angioedema with icatibant: Efficacy in clinical trials versus effectiveness in the real-world setting
-
Maurer M, Longhurst HJ, Fabien V, et al. Treatment of hereditary angioedema with icatibant: Efficacy in clinical trials versus effectiveness in the real-world setting. Allergy Asthma Proc 35:377-381, 2014.
-
(2014)
Allergy Asthma Proc
, vol.35
, pp. 377-381
-
-
Maurer, M.1
Longhurst, H.J.2
Fabien, V.3
-
14
-
-
84865615187
-
Hereditary angioedema treatment options: The availability of new therapies
-
Aberer W. Hereditary angioedema treatment options: The availability of new therapies. Ann Med 44:523-529, 2012.
-
(2012)
Ann Med
, vol.44
, pp. 523-529
-
-
Aberer, W.1
-
15
-
-
84894235031
-
Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema
-
Aberer W, Maurer M, Reshef A, et al. Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema. Allergy 69:305-314, 2014.
-
(2014)
Allergy
, vol.69
, pp. 305-314
-
-
Aberer, W.1
Maurer, M.2
Reshef, A.3
-
17
-
-
79952051526
-
Management of acute attacks of hereditary angioedema: Potential role of icatibant
-
Longhurst HJ. Management of acute attacks of hereditary angioedema: Potential role of icatibant. Vasc Health Risk Manag 6:795-802, 2010.
-
(2010)
Vasc Health Risk Manag
, vol.6
, pp. 795-802
-
-
Longhurst, H.J.1
-
18
-
-
79953187961
-
Diagnosis and management of hereditary angioedema
-
Johnston DT. Diagnosis and management of hereditary angioedema. J Am Osteopath Assoc 111:28-36, 2011.
-
(2011)
J Am Osteopath Assoc
, vol.111
, pp. 28-36
-
-
Johnston, D.T.1
-
19
-
-
84855779242
-
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group
-
Cicardi M, Bork K, Caballero T, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group. Allergy 67:147-157, 2012.
-
(2012)
Allergy
, vol.67
, pp. 147-157
-
-
Cicardi, M.1
Bork, K.2
Caballero, T.3
-
20
-
-
84924959789
-
Pharmacokinetics of single and repeat doses of icatibant
-
10.1002/cpdd.138
-
Leach JK, Spencer K, Mascelli M, et al. Pharmacokinetics of single and repeat doses of icatibant. Clin Pharm Drug Dev 10.1002/cpdd.138, 2014.
-
(2014)
Clin Pharm Drug Dev
-
-
Leach, J.K.1
Spencer, K.2
Mascelli, M.3
-
21
-
-
84942567681
-
Icatibant for the treatment of repeated attacks of hereditary angioedema: FAST-3 trial openlabel extension study phase
-
Lumry W, Levy R, Li H, et al. Icatibant for the treatment of repeated attacks of hereditary angioedema: FAST-3 trial openlabel extension study phase. Allergy 68(suppl. 97):254-255, 2013.
-
(2013)
Allergy
, vol.68
, pp. 254-255
-
-
Lumry, W.1
Levy, R.2
Li, H.3
|